JAK Inhibitor Improves Symptoms, Anemia in Myelofibrosis

(MedPage Today) -- Ed Uthman CC BY 2.0 Myelofibrosis treatment with the Janus kinase (JAK) inhibitor momelotinib resulted in clinically significant improvements in symptoms and spleen response compared with danazol for symptomatic, JAK inhibitor...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news